Overview
This PhD research focuses on developing magnetic nanobots for targeted cancer therapy. By harnessing externally controlled magnetic fields, these nanoscale devices can navigate to tumour sites, enabling precise drug delivery while minimizing damage to healthy tissues. The work aims to improve treatment efficacy, reduce side effects, and advance personalized cancer therapies.
About this opportunity
Cancer remains one of the leading causes of mortality worldwide, and while conventional treatments such as chemotherapy and radiotherapy can be effective, they often suffer from poor specificity and significant side effects due to damage to healthy tissues. Targeted drug delivery technologies offer a promising strategy to overcome these limitations by selectively transporting therapeutic agents directly to tumour sites, enhancing treatment efficacy while reducing systemic toxicity.
Magnetic nanobots represent an emerging and highly innovative approach to targeted cancer therapy. These nanoscale devices can be remotely guided using externally applied magnetic fields, enabling precise navigation through the body to reach diseased tissues. By combining controlled motion, targeted delivery, and responsive therapeutic functions, magnetic nanobots have the potential to revolutionise cancer treatment and support the development of personalised medicine.
This PhD project will focus on the design, fabrication, and optimisation of magnetic nanobots for targeted cancer therapy. The research will investigate advanced nanomaterials and magnetic guidance systems to develop nanobots capable of delivering therapeutic payloads directly to tumour sites with high precision. The project will address key challenges including biocompatibility, navigation efficiency, payload loading, controlled drug release, and therapeutic effectiveness.
The student will work across nanotechnology, biomaterials engineering, cancer biology, and biomedical engineering to design, synthesise, and characterise functional magnetic nanobot systems. Training will include nanoparticle synthesis, surface functionalisation, magnetic characterisation, microscopy, microfabrication techniques, and advanced materials analysis. The project will also involve evaluating nanobot performance using in vitro cancer models and investigating their ability to target, penetrate, and destroy tumour cells under controlled magnetic guidance.
As the research progresses, the developed nanobot platforms may be assessed in increasingly complex biological environments to explore their translational potential for clinical cancer treatment. Particular emphasis will be placed on improving targeting accuracy, therapeutic efficiency, and safety compared with conventional drug delivery approaches.
This studentship offers an exciting opportunity to contribute to the development of next-generation cancer therapeutics at the intersection of nanotechnology, robotics, materials science, and medicine. The multidisciplinary skills gained throughout the project will prepare the student for future careers in academia, biotechnology, medical devices, pharmaceutical research, and advanced healthcare technologies.
Further reading
1. Sujaritha Jayaraj et al. Nanocarrier-based strategies for advanced cancer drug delivery and therapeutics: Design principles, biological interactions, and clinical potential, Nano Trends,14, 2026,100203.
2. Md Asraful Alam et al, Emerging smart nanocarrier based drug delivery systems for cancer therapeutics,Next Nanotechnology, 9, 2026,100387,
3.
Subham Preetal et al, Targeting brain tumours with precision: advances in magnetic nanoparticle therapyNanoscale Advances., 2026,8, 458-478